These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38626)

  • 1. Effects of 4-aminopyridine on statistical parameters of transmitter release at the neuromuscular junction.
    Lundh H
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):343-6. PubMed ID: 38626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI
    Can J Physiol Pharmacol; 1987 May; 65(5):747-52. PubMed ID: 2887267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.
    Wiegand H; Lohmann H; Chandra SV
    Arch Toxicol; 1986 Apr; 58(4):265-70. PubMed ID: 2424403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitatory effects of 4-aminopyridine on strontium-mediated evoked and delayed transmitter release from motor nerve terminals.
    Molgó J; Lemeignan M; Guerrero S
    Eur J Pharmacol; 1982 Oct; 84(1-2):1-7. PubMed ID: 6128233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.
    Lundh H; Thesleff S
    Eur J Pharmacol; 1977 Apr; 42(4):411-2. PubMed ID: 15849
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenocorticotropic hormone causes long-lasting potentiation of transmitter release from frog motor nerve terminals.
    Johnston MF; Kravitz EA; Meiri H; Rahamimoff R
    Science; 1983 Jun; 220(4601):1071-2. PubMed ID: 6133353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS; Lambert JJ; Marshall IG
    Br J Pharmacol; 1979 Jan; 65(1):53-62. PubMed ID: 216450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Aminopyridine and evoked transmitter release from motor nerve endings.
    Illes P; Thesleff S
    Br J Pharmacol; 1978 Dec; 64(4):623-9. PubMed ID: 31961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of kanamycin on evoked transmitter release. Reversal by 3,4-diaminopyridine.
    Molgó J; Lemeignan M; Uchiyama T; Lechat P
    Eur J Pharmacol; 1979 Jul; 57(1):93-7. PubMed ID: 38977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual action of ouabain on transmitter release at neuromuscular junctions of the frog.
    Brănişteanu DD; Proca B; Haulică ID
    J Pharmacol Exp Ther; 1979 Apr; 209(1):31-6. PubMed ID: 34716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J; Lemeignan M; Lechat P
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve terminal facilitatory action of 4-aminopyridine: an analysis of the rising phase of the endplate potential.
    Jacobs RS; Burley ES
    Neuropharmacology; 1978 Jul; 17(7):439-44. PubMed ID: 692810
    [No Abstract]   [Full Text] [Related]  

  • 18. The action of verapamil on the rate of spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):119-27. PubMed ID: 33814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 4-aminopyridine on nerve terminal action potentials.
    Burley ES; Jacobs RS
    J Pharmacol Exp Ther; 1981 Oct; 219(1):268-73. PubMed ID: 7288611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.